CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — U.S. September 22, 2021–February 6, 2022
-
February 11, 2022
-
-
Source: MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release
Details:
-
Personal Author:
-
Corporate Authors:
-
Description:What is already known about this topic? In preauthorization trials, adverse reactions were reported less frequently following a homologous COVID-19 mRNA vaccine booster dose than after receipt of the second primary dose.
What is added by this report? Review of Surveillance data found that local and systemic reactions were less frequent after a homologous COVID-19 mRNA vaccine booster dose than after the second primary vaccine dose. Myocarditis was rarely reported following an mRNA vaccine booster dose.
What are the implications for public health practice? All persons aged ≥12 years should receive a COVID-19 booster dose. Vaccination providers should educate patients that local and systemic reactions are expected following a homologous COVID-19 mRNA vaccine booster; however, these reactions are less common than those following the second primary series dose.
Suggested citation for this article: Hause AM, Baggs J, Marquez P, et al. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — U.S. September 22, 2021–February 6, 2022. MMWR Morb Mortal Wkly Rep. ePub: 11 February 2022.
mm7107e1.htm?s_cid=mm7107e1_w
mm7107e1-H.pdf
-
Subjects:
-
Source:
-
Series:
-
ISSN:0149-2195 (print);1545-861X (digital);
-
Document Type:
-
Name as Subject:
-
Place as Subject:
-
Pages in Document:6 pdf pages
-
Volume:71
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: